Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Operating Leases (2019 - 2025)

Catheter Precision (VTAK) has disclosed Operating Leases for 7 consecutive years, with $114000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases fell 15.56% to $114000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $114000.0, a 15.56% decrease, with the full-year FY2024 number at $13000.0, down 93.09% from a year prior.
  • Operating Leases was $114000.0 for Q3 2025 at Catheter Precision, up from $94000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $2.1 million in Q3 2021 to a low of $3000.0 in Q1 2025.
  • A 5-year average of $582266.7 and a median of $121000.0 in 2023 define the central range for Operating Leases.
  • Biggest YoY gain for Operating Leases was 51.61% in 2025; the steepest drop was 96.55% in 2025.
  • Catheter Precision's Operating Leases stood at $2.0 million in 2021, then decreased by 11.86% to $1.7 million in 2022, then tumbled by 89.23% to $188000.0 in 2023, then tumbled by 93.09% to $13000.0 in 2024, then skyrocketed by 776.92% to $114000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Operating Leases are $114000.0 (Q3 2025), $94000.0 (Q2 2025), and $3000.0 (Q1 2025).